Cognitive impairment in remitted patients with bipolar disorder

Chumakov E.M.; Petrova N.N.; Limankin O.V.; Ashenbrenner Yu.V.

doi:https://doi.org/10.17116/jnevro202112104112

Chumakov E.M.

St. Petersburg State University;
Kashchenko Psychiatric Hospital No. 1

Petrova N.N.

Saint-Petersburg State University

ORCID: 0000-0003-4096-6208

Limankin O.V.

Kashchenko Psychiatric Hospital No. 1;
St. Petersburg Institute of Advanced Training of Medical Experts;
Mechnikov North-Western State Medical University

Ashenbrenner Yu.V.

St. Petersburg State University;
Kashchenko Psychiatric Hospital No. 1

Cognitive impairment in remitted patients with bipolar disorder

Authors:

Chumakov E.M., Petrova N.N., Limankin O.V., Ashenbrenner Yu.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4): 12‑18

DOI: 10.17116/jnevro202112104112

Read: 10284 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Chumakov EM, Petrova NN, Limankin OV, Ashenbrenner YuV. Cognitive impairment in remitted patients with bipolar disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4):12‑18. (In Russ.)
https://doi.org/10.17116/jnevro202112104112

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To assess the frequency and severity of cognitive impairment as well as its correlations with clinical characteristics in remitted patients with bipolar disorder (BD).

MATERIAL AND METHODS

Eighty-five patients with BD type I (64 patients) and BD type II (21 patients) in remission were examined (average age 36.6±5.7). Affective symptoms were assessed using the Hamilton Depression Rating Scale (HDRS) and Young’s Mania Rating Scale (YMRS). Cognitive impairment was assessed using the Brief Neuropsychological Cognitive Examination (BNCE).

RESULTS

Cognitive impairment was revealed in 43.5% of the patients. The frequency and structure of cognitive impairment in patients with BD type I and type II did not differ. The patients with cognitive impairment were characterized by decreased speed of mental processes, decreased working memory and attention deficit. The correlation of the total BNCE score with the age of the patients, duration of the disease, total HDRS and YMRS scores was revealed.

CONCLUSION

The results demonstrate the affective nature of cognitive deficit in the patients. Cognitive impairment in remitted patients with BD is a significant therapeutic target.

Keywords:

bipolar disorder

remission

cognitive impairment

residual symptoms

Authors:

Chumakov E.M.

St. Petersburg State University;
Kashchenko Psychiatric Hospital No. 1

Petrova N.N.

Saint-Petersburg State University

ORCID: 0000-0003-4096-6208

Limankin O.V.

Kashchenko Psychiatric Hospital No. 1;
St. Petersburg Institute of Advanced Training of Medical Experts;
Mechnikov North-Western State Medical University

Ashenbrenner Yu.V.

St. Petersburg State University;
Kashchenko Psychiatric Hospital No. 1

Received:

25.06.2020

Accepted:

13.07.2020

Close metadata

References:

Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15:425–434. https://doi.org/10.1016/j.euroneuro.2005.04.011
Weinstock LM, Strong D, Uebelacker LA, Miller IW. DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania. J Psychiatr Res. 2010;44(14):979–985. https://doi.org/10.1016/j.jpsychires.2010.03.010
Gitlin MJ, Miklowitz DJ. The difficult lives of individuals with bipolar disorder: a review of functional outcomes and their implications for treatment. J Affect Disord. 2017;209:147–154. https://doi.org/10.1016/j.jad.2016.11.021
Rosenblat JD, Simon GE, Sachs GS, et al. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord. 2019;243:116–120. https://doi.org/10.1016/j.jad.2018.09.027
Rocha P, Correa H. The impact of clinical comorbidities and residual depressive symptoms in sleep quality in euthymic/interepisodic bipolar subjects. Psychiatry Res. 2018;268:165–168. https://doi.org/10.1016/j.psychres.2018.07.002
Martínez-Arán A, Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol. 2015;25(2):151–157. https://doi.org/10.1016/j.euroneuro.2015.01.007
Miller S, Dell’Osso B, Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169(Suppl 1):3–11. https://doi.org/10.1016/s0165-0327(14)70003-5
Petrova NN, Ashenbrenner YuV. Bipolar disorder type I and patients’ psychosocial functioning. Sotsial’naya i Klinicheskaya Psikhiatriya. 2018;28(1):10–14. (In Russ.).
Fagiolini A, Kupfer DJ, Masalehdan A, et al. Functional impairment in the remission phase of bipolar disorder. Bipolar Disord. 2015;7(3):281–285. https://doi.org/10.1111/j.1399-5618.2005.00207.x
Volkert J, Schiele MA, Kazmaier J, et al. Cognitive deficits in bipolar disorder: From acute episode to remission. Eur Arch Psychiatry Clin Neurosci. 2016;266(3):225–237. https://doi.org/10.1007/s00406-015-0657-2
Smulevich AB, Andryushchenko AV, Romanov DV, Zakharova NV. Remissions in affective disorders: epidemiology, psychopathology, clinical and social prognosis, treatment. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114(3):4-13. (In Russ.).
Ashenbrenner YuV, Chumakov EM, Petrova NN. Residual symptoms and their impact on social functioning in patients with bipolar disorder in remission. Nevrologicheski Vestnik. 2019;51(2):66–71. (In Russ.). https://doi.org/10.17816/nb15665
Konoreva AE, Mosolov SN. Cognitive Impairment in Bipolar Affective Disorder. Sovremennaya Terapiya Psikhicheskikh rasstroistv. 2017;(4):11–18. (In Russ.). https://doi.org/10.21265/PSYPH.2017.43.8416
Solé B, Jimenez E, Torrent C, et al. Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies. Int J Neuropsychopharmacol. 2017;20(8):670–680. https://doi.org/10.1093/ijnp/pyx032
Engel J. Visions for novel biophysical elucidations of extracellular matrix networks. Int J Biochem Cell Biol. 2007;39(2):311–318. https://doi.org/10.1016/j.biocel.2006.08.003
Rosa AR, Bonnin CM, Vazquez GH, et al. Functional impairment in bipolar II disorder: Is it as disabling as bipolar I? J Affect Disord. 2010;127(1–3):71–6. https://doi.org/10.1016/j.jad.2010.05.014
Toyoshima K, Kako Y, Toyomaki A, et al. Associations between cognitive impairment and quality of life in euthymic bipolar patients. Psychiatry Res. 2019;271:510–515. https://doi.org/10.1016/j.psychres.2018.11.061
Veeh J, Kopf J, Kittel-Schneider S, et al. Cognitive re mediation for bipolar patients with objective cognitive impairment: a naturalistic study. Int J Bipolar Disord. 2017;5(1):8. https://doi.org/10.1186/s40345-017-0079-3
Daglas R, Yucel M, Cotton S, et al. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. Int J Bipolar Disord. 2015;3:9. https://doi.org/10.1186/s40345-015-0024-2
Samalin L, Bellivier F, Giordana B, et al. Patients’ Perspectives on Residual Symptoms in Bipolar Disorder: A Focus Group Study. J Nerv Ment Dis. 2014;202(7):550–555. https://doi.org/10.1097/nmd.0000000000000157
Roux P, Raust A, Cannavo A-S, et al. Associations between residual depressive symptoms, cognition, and functioning in patients with euthymic bipolar disorder: results from the FACE-BD cohort. Br J Psychiatry. 2017;211(6):381–387. https://doi.org/10.1192/bjp.bp.117.201335
Post F, Pardeller S, Frajo-Apor B, et al. Quality of life in stabilized outpatients with bipolar I disorder: Associations with resilience, internalized stigma, and residual symptoms. J Affect Disord. 2018;238:399–404. https://doi.org/10.1016/j.jad.2018.05.055
Cipriani G, Danti S, Carlesi C, et al. Bipolar Disorder and Cognitive Dysfunction: A Complex Link. J Nerv Ment Dis. 2017;205(10):743–756. https://doi.org/10.1097/nmd.0000000000000720
Martínez-Arán A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–232. https://doi.org/10.1111/j.1399-5618.2004.00111.x
Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E. Cognitive Impairment in Bipolar Disorder: Neurodevelopment or Neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol. 2008;18(11):787–793. https://doi.org/10.1016/j.euroneuro.2008.07.005
Riedel P, Smolka MN, Bauer M. Schizophrenia and bipolar disorder: Treatment of cognitive impairments. Nervenarzt. 2018;89(7):784–795. https://doi.org/10.1007/s00115-018-0500-x
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. https://doi.org/10.1136/jnnp.23.1.56
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429–435. https://doi.org/10.1192/bjp.133.5.429
Tonkonogii IM; Mikadze Yu.V., ed. Kratkoe neiropsikhologicheskoe obsledovanie kognitivnoi sfery (KNOKS). Moscow; 2010. (In Russ.).
Chumakov EM. Cognitive impairment and mental disorders in HIV-infected patients with early stages of syphilis. Vestnik Sankt-Peterburgskogo universiteta. Seriya 11. Meditsina. 2017;12(3):273–277. https://doi.org/10.21638/11701/spbu11.2017.307
Niinoja IV, Romanov DV, Makhmudova GZ, Nodel MR. Depression in Parkinson’s Disease: Aspects of the Psychopathological Structure and Nosological Qualification. Psychiatry. 2019;17(4):38–48. (In Russ.). https://doi.org/10.30629/2618-6667-2019-17-4-38-48
Mosolov SN, Ushkalova AV, Kostyukova EG, et al. Validation of the HCL-32 russian version for detection of bipolar ii disorder patients among those with diagnosis of recurrent depressive disorder. Sotsial’naya i klinicheskaya psikhiatriya. 2015;25(1):22–30. (In Russ.).
Szmulewicz AG, Valerio MP, Smith JM, et al. Neuropsychological Profiles of Major Depressive Disorder and Bipolar Disorder During Euthymia. A Systematic Literature Review of Comparative Studies. Psychiatry Res. 2017;248:127–133. https://doi.org/10.1016/j.psychres.2016.12.031
Xu G, Lin K, Rao D, et al. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord. 2012;136(3):328–339. https://doi.org/10.1016/j.jad.2011.11.029
Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology. 2009;23(5):551–562. https://doi.org/10.1037/a0016277
Vasserman LI, Berezentseva MS, Ershov BB, Shchelkunova LA. Neiropsikhologicheskaya otsenka kognitivnykh narushenii u patsientov s endogennymi depressivnymi rasstroistvami. Vestnik Yuzhno-Ural’skogo gosudarstvennogo universiteta. Seriya: Psikhologiya. 2012;(31):92–96. (In Russ.).
Glahn DC, Almasy L, Barguil M, et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry. 2010;67(2):168–177. https://doi.org/10.1001/archgenpsychiatry.2009.184
Balanza-Martinez V, Rubio C, Selva-Vera G, et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev. 2008;32(8):1426–1438. https://doi.org/10.1016/j.neubiorev.2008.05.019
Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow up. J Affect Disord. 2004;81(2):123–131. https://doi.org/10.1016/s0165-0327(03)00161-7
Bonnin CM, Sanchez-Moreno J, Martinez-Aran A, et al. Subthreshold symptoms in bipolar disorder: Impact on neurocognition, quality of life and disability. J Affect Disord. 2012;136(3):650–659. https://doi.org/10.1016/j.jad.2011.10.012
Kuppili PP, Menon V, Chandrasekaran V, Navin K. Biological Rhythm Impairment in Bipolar Disorder: A State or Trait Marker? Indian J Psychiatry. 2018;60(4):404–409. https://doi.org/10.4103/psychiatry.indianjpsychiatry_110_18
Konstantakopoulos G, Ioannidi N, Typaldou M, et al. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder. Psychiatriki. 2016;27(3):182–191. https://doi.org/10.22365/jpsych.2016.273.182
Fuentes I, Rizo-Mendez A, Jarne-Esparcia A. Low compliance to pharmacological treatment is linked to cognitive impairment in euthymic phase of bipolar disorder. J Affect Disord. 2016;195:215–220. https://doi.org/10.1016/j.jad.2016.02.005